API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
13
PharmaCompass offers a list of Prazosin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prazosin Hydrochloride manufacturer or Prazosin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prazosin Hydrochloride manufacturer or Prazosin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Prazosin Hydrochloride API Price utilized in the formulation of products. Prazosin Hydrochloride API Price is not always fixed or binding as the Prazosin Hydrochloride Price is obtained through a variety of data sources. The Prazosin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Prazosin HCL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prazosin HCL, including repackagers and relabelers. The FDA regulates Prazosin HCL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prazosin HCL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prazosin HCL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prazosin HCL supplier is an individual or a company that provides Prazosin HCL active pharmaceutical ingredient (API) or Prazosin HCL finished formulations upon request. The Prazosin HCL suppliers may include Prazosin HCL API manufacturers, exporters, distributors and traders.
click here to find a list of Prazosin HCL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Prazosin HCL DMF (Drug Master File) is a document detailing the whole manufacturing process of Prazosin HCL active pharmaceutical ingredient (API) in detail. Different forms of Prazosin HCL DMFs exist exist since differing nations have different regulations, such as Prazosin HCL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Prazosin HCL DMF submitted to regulatory agencies in the US is known as a USDMF. Prazosin HCL USDMF includes data on Prazosin HCL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prazosin HCL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Prazosin HCL suppliers with USDMF on PharmaCompass.
A Prazosin HCL CEP of the European Pharmacopoeia monograph is often referred to as a Prazosin HCL Certificate of Suitability (COS). The purpose of a Prazosin HCL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prazosin HCL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prazosin HCL to their clients by showing that a Prazosin HCL CEP has been issued for it. The manufacturer submits a Prazosin HCL CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prazosin HCL CEP holder for the record. Additionally, the data presented in the Prazosin HCL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prazosin HCL DMF.
A Prazosin HCL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prazosin HCL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Prazosin HCL suppliers with CEP (COS) on PharmaCompass.
A Prazosin HCL written confirmation (Prazosin HCL WC) is an official document issued by a regulatory agency to a Prazosin HCL manufacturer, verifying that the manufacturing facility of a Prazosin HCL active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Prazosin HCL APIs or Prazosin HCL finished pharmaceutical products to another nation, regulatory agencies frequently require a Prazosin HCL WC (written confirmation) as part of the regulatory process.
click here to find a list of Prazosin HCL suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prazosin HCL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Prazosin HCL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Prazosin HCL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Prazosin HCL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prazosin HCL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Prazosin HCL suppliers with NDC on PharmaCompass.
Prazosin HCL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prazosin HCL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prazosin HCL GMP manufacturer or Prazosin HCL GMP API supplier for your needs.
A Prazosin HCL CoA (Certificate of Analysis) is a formal document that attests to Prazosin HCL's compliance with Prazosin HCL specifications and serves as a tool for batch-level quality control.
Prazosin HCL CoA mostly includes findings from lab analyses of a specific batch. For each Prazosin HCL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prazosin HCL may be tested according to a variety of international standards, such as European Pharmacopoeia (Prazosin HCL EP), Prazosin HCL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prazosin HCL USP).